Literature DB >> 23831231

Peroxiredoxin V selectively regulates IL-6 production by modulating the Jak2-Stat5 pathway.

Hoon-In Choi1, Kyoung-Jin Chung2, Hee-Young Yang1, Lina Ren1, Sungoh Sohn1, Poo-Reun Kim3, Min-Suk Kook3, Hyon E Choy4, Tae-Hoon Lee5.   

Abstract

Mammalian peroxiredoxin V (PrdxV) is a multifunctional protein that protects cells from DNA damage and inhibits stress-induced apoptosis. However, PrdxV is also known to be involved in modulating lipopolysaccharide (LPS)-induced host cell signaling, but its precise role is not fully understood. In this study, we used stably transfected RAW264.7 cells and transiently transfected 293-mTLR4-MD2-CD14 cells expressing wild-type (WT) or mutant (C48S) PrdxV to characterize the function and mechanism of action of PrdxV in LPS-induced immune responses. We found that PrdxV selectively reduces production of interleukin 6 (IL-6) by inhibiting activation of signal transducer and activator of transcription 5 (Stat5) through interaction with Jak2. Notably, this activity of PrdxV was dependent on its catalytic Cys48 residue, but not its peroxidase activity. The binding of to Jak2 effectively inhibited Jak2 phosphorylation, but PrdxV did not act as efficiently as SOCS1 (suppressor of cytokine signaling 1). Our results suggest that PrdxV is a key mediator contributing to the regulation of LPS/TLR4-induced immune responses.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD14; G-CSF; H(2)O(2); IFN-β; IL-6; Jak2; Jak2/Stat5 pathway; LPS; MAL; MAPKs; MD2; N-acetyl-L-cysteine; NAC; NF-κB; Peroxiredoxin V; PrdxV; RANTES; ROS; SOCS1; Stat5; TLR4; TNF-α; TRAM; TRIF; TRIF-related adaptor molecule; Toll/I-1 receptor domain-containing adaptor inducing interferon-β; cluster of differentiation; granulocyte colony-stimulating factor; hydrogen peroxide; interferon β; interleukin 6; janus kinase 2; lipopolysaccaride; mitogen-activated protein kinases; myD88-adaptor-like protein; myeloid differentiation protein; nuclear factor kappa B; peroxiredoxin V; reactive oxygen species; regulated on activation, normal T-cell expressed, and secreted; signal transducer and activator of transcription 5; suppressor of cytokine signaling 1; toll like receptor 4; tumor necrosis factor α

Mesh:

Substances:

Year:  2013        PMID: 23831231     DOI: 10.1016/j.freeradbiomed.2013.06.038

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

Review 1.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

2.  Interaction of peroxiredoxin V with dihydrolipoamide branched chain transacylase E2 (DBT) in mouse kidney under hypoxia.

Authors:  Sun Hee Ahn; Hee-Young Yang; Gia Buu Tran; Joseph Kwon; Kyu-Yeol Son; Suhee Kim; Quoc Thuong Dinh; Seunggon Jung; Ha-Mi Lee; Kyoung-Oh Cho; Tae-Hoon Lee
Journal:  Proteome Sci       Date:  2015-02-05       Impact factor: 2.480

3.  Peroxiredoxin 5 Protects TGF-β Induced Fibrosis by Inhibiting Stat3 Activation in Rat Kidney Interstitial Fibroblast Cells.

Authors:  Hoon-In Choi; Seong Kwon Ma; Eun Hui Bae; JongUn Lee; Soo Wan Kim
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

4.  Peroxiredoxin V (PrdxV) negatively regulates EGFR/Stat3-mediated fibrogenesis via a Cys48-dependent interaction between PrdxV and Stat3.

Authors:  Hoon-In Choi; Dong-Hyun Kim; Jung Sun Park; In Jin Kim; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Tae-Hoon Lee; Soo Wan Kim
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

Review 5.  IL-6: The Link Between Inflammation, Immunity and Breast Cancer.

Authors:  Juan Chen; Yanghui Wei; Weiqin Yang; Qingnan Huang; Yong Chen; Kai Zeng; Jiawei Chen
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

Review 6.  Multiple Roles of Peroxiredoxins in Inflammation.

Authors:  Bernard Knoops; Vasiliki Argyropoulou; Sarah Becker; Laura Ferté; Oksana Kuznetsova
Journal:  Mol Cells       Date:  2016-01-25       Impact factor: 5.034

7.  A key metabolic integrator, coenzyme A, modulates the activity of peroxiredoxin 5 via covalent modification.

Authors:  Jovana Baković; Bess Yi Kun Yu; Daniel Silva; Sew Peak Chew; Sangeun Kim; Sun-Hee Ahn; Laura Palmer; Lujain Aloum; Giacomo Stanzani; Oksana Malanchuk; Michael R Duchen; Mervyn Singer; Valeriy Filonenko; Tae-Hoon Lee; Mark Skehel; Ivan Gout
Journal:  Mol Cell Biochem       Date:  2019-08-02       Impact factor: 3.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.